Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 483

1.

Sarcoplasmic reticulum calcium leak contributes to arrhythmia but not to heart failure progression.

Mohamed BA, Hartmann N, Tirilomis P, Sekeres K, Li W, Neef S, Richter C, Zeisberg EM, Kattner L, Didié M, Guan K, Schmitto JD, Lehnart SE, Luther S, Voigt N, Seidler T, Sossalla S, Hasenfuss G, Toischer K.

Sci Transl Med. 2018 Sep 12;10(458). pii: eaan0724. doi: 10.1126/scitranslmed.aan0724.

PMID:
30209242
2.

Temporal changes within mechanical dyssynchrony and rotational mechanics in Takotsubo syndrome: A cardiovascular magnetic resonance imaging study.

Backhaus SJ, Stiermaier T, Lange T, Chiribiri A, Lamata P, Uhlig J, Kowallick JT, Raaz U, Villa A, Lotz J, Hasenfuß G, Thiele H, Eitel I, Schuster A.

Int J Cardiol. 2018 Apr 22. pii: S0167-5273(18)30123-2. doi: 10.1016/j.ijcard.2018.04.088. [Epub ahead of print]

3.

[InterAtrial Shunt Device in diastolic heart failure].

Hasenfuß G, Jacobshagen C.

Internist (Berl). 2018 Sep 7. doi: 10.1007/s00108-018-0484-4. [Epub ahead of print] Review. German.

PMID:
30194481
4.

Activation of protein phosphatase 1 by a selective phosphatase disrupting peptide reduces sarcoplasmic reticulum Ca2+ leak in human heart failure.

Fischer TH, Eiringhaus J, Dybkova N, Saadatmand A, Pabel S, Weber S, Wang Y, Köhn M, Tirilomis T, Ljubojevic S, Renner A, Gummert J, Maier LS, Hasenfuß G, El-Armouche A, Sossalla S.

Eur J Heart Fail. 2018 Sep 7. doi: 10.1002/ejhf.1297. [Epub ahead of print]

PMID:
30191648
5.

[Inherited heart diseases and storage diseases with cardiac involvement].

Czepluch FS, Hasenfuß G.

Internist (Berl). 2018 Sep 3. doi: 10.1007/s00108-018-0485-3. [Epub ahead of print] German.

PMID:
30178098
6.

Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).

Emami A, Saitoh M, Valentova M, Sandek A, Evertz R, Ebner N, Loncar G, Springer J, Doehner W, Lainscak M, Hasenfuß G, Anker SD, von Haehling S.

Eur J Heart Fail. 2018 Aug 30. doi: 10.1002/ejhf.1304. [Epub ahead of print]

PMID:
30160804
7.

High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis.

Xu X, Tan X, Tampe B, Wilhelmi T, Hulshoff MS, Saito S, Moser T, Kalluri R, Hasenfuss G, Zeisberg EM, Zeisberg M.

Nat Commun. 2018 Aug 29;9(1):3509. doi: 10.1038/s41467-018-05766-5.

8.

Right ventricular strain assessment by cardiovascular magnetic resonance myocardial feature tracking allows optimized risk stratification in Takotsubo syndrome.

Stiermaier T, Lange T, Chiribiri A, Möller C, Graf T, Raaz U, Villa A, Kowallick JT, Lotz J, Hasenfuß G, Thiele H, Schuster A, Eitel I.

PLoS One. 2018 Aug 29;13(8):e0202146. doi: 10.1371/journal.pone.0202146. eCollection 2018.

9.

Long-Term Prognosis of Patients With Takotsubo Syndrome.

Ghadri JR, Kato K, Cammann VL, Gili S, Jurisic S, Di Vece D, Candreva A, Ding KJ, Micek J, Szawan KA, Bacchi B, Bianchi R, Levinson RA, Wischnewsky M, Seifert B, Schlossbauer SA, Citro R, Bossone E, Münzel T, Knorr M, Heiner S, D'Ascenzo F, Franke J, Sarcon A, Napp LC, Jaguszewski M, Noutsias M, Katus HA, Burgdorf C, Schunkert H, Thiele H, Bauersachs J, Tschöpe C, Pieske BM, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Hasenfuß G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Empen K, Felix SB, Delmas C, Lairez O, El-Battrawy I, Akin I, Borggrefe M, Horowitz J, Kozel M, Tousek P, Widimský P, Gilyarova E, Shilova A, Gilyarov M, Winchester DE, Ukena C, Bax JJ, Prasad A, Böhm M, Lüscher TF, Ruschitzka F, Templin C.

J Am Coll Cardiol. 2018 Aug 21;72(8):874-882. doi: 10.1016/j.jacc.2018.06.016.

PMID:
30115226
10.

[Genetics in medicine].

Haller H, Hasenfuß G, Schäfer JR.

Internist (Berl). 2018 Aug;59(8):753-755. doi: 10.1007/s00108-018-0463-9. German. No abstract available.

PMID:
30039391
11.

Differential multivariable risk prediction of appropriate shock versus competing mortality - A prospective cohort study to estimate benefits from ICD therapy.

Bergau L, Willems R, Sprenkeler DJ, Fischer TH, Flevari P, Hasenfuß G, Katsaras D, Kirova A, Lehnart SE, Lüthje L, Röver C, Seegers J, Sossalla S, Dunnink A, Sritharan R, Tuinenburg AE, Vandenberk B, Vos MA, Wijers SC, Friede T, Zabel M.

Int J Cardiol. 2018 Jun 28. pii: S0167-5273(18)32262-9. doi: 10.1016/j.ijcard.2018.06.103. [Epub ahead of print]

12.

[Iron deficiency in heart failure. A new diagnostic therapy algorithm - evidence-tested and workable].

Erdmann E, Bauersachs J, Doehner W, Hasenfuß G, Kindermann I, Ringwald G, Rybak K, Schieffer B, Zeiher AM.

MMW Fortschr Med. 2018 Jul;160(Suppl 4):8-11. doi: 10.1007/s15006-018-0726-3. Epub 2018 Jul 4. German.

PMID:
29974435
13.

[Modern genetic counselling : Practical aspects exemplified by hypertrophic cardiomyopathy].

Czepluch F, Hasenfuß G, Wollnik B.

Internist (Berl). 2018 Aug;59(8):790-798. doi: 10.1007/s00108-018-0452-z. Review. German.

PMID:
29943241
14.

Differential regulation of sodium channels as a novel proarrhythmic mechanism in the human failing heart.

Dybkova N, Ahmad S, Pabel S, Tirilomis P, Hartmann N, Fischer TH, Bengel P, Tirilomis T, Ljubojevic S, Renner A, Gummert J, Ellenberger D, Wagner S, Frey N, Maier LS, Streckfuss-Boemeke K, Hasenfuss G, Sossalla S.

Cardiovasc Res. 2018 Jun 20. doi: 10.1093/cvr/cvy152. [Epub ahead of print]

PMID:
29931291
15.

Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes.

Cyganek L, Tiburcy M, Sekeres K, Gerstenberg K, Bohnenberger H, Lenz C, Henze S, Stauske M, Salinas G, Zimmermann WH, Hasenfuss G, Guan K.

JCI Insight. 2018 Jun 21;3(12). pii: 99941. doi: 10.1172/jci.insight.99941. [Epub ahead of print]

16.

Correction: Inter-vendor reproducibility of left and right ventricular cardiovascular magnetic resonance myocardial feature-tracking.

Gertz RJ, Lange T, Kowallick JT, Backhaus SJ, Steinmetz M, Staab W, Kutty S, Hasenfuß G, Lotz J, Schuster A.

PLoS One. 2018 Jun 18;13(6):e0199489. doi: 10.1371/journal.pone.0199489. eCollection 2018.

17.

Left ventricular myocardial deformation in Takotsubo syndrome: a cardiovascular magnetic resonance myocardial feature tracking study.

Stiermaier T, Lange T, Chiribiri A, Möller C, Graf T, Villnow C, Raaz U, Villa A, Kowallick JT, Lotz J, Hasenfuß G, Thiele H, Schuster A, Eitel I.

Eur Radiol. 2018 Jun 7. doi: 10.1007/s00330-018-5475-2. [Epub ahead of print]

PMID:
29882071
18.

Left Atrial Pressure: The Key to Understand and Treat HFpEF?

Hasenfuss G.

JACC Heart Fail. 2018 Aug;6(8):676-677. doi: 10.1016/j.jchf.2018.04.004. Epub 2018 May 23. No abstract available.

PMID:
29803553
19.

A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation.

Abraham WT, Kuck KH, Goldsmith RL, Lindenfeld J, Reddy VY, Carson PE, Mann DL, Saville B, Parise H, Chan R, Wiegn P, Hastings JL, Kaplan AJ, Edelmann F, Luthje L, Kahwash R, Tomassoni GF, Gutterman DD, Stagg A, Burkhoff D, Hasenfuß G.

JACC Heart Fail. 2018 May 5. pii: S2213-1779(18)30303-2. doi: 10.1016/j.jchf.2018.04.010. [Epub ahead of print]

20.

Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.

Ravassa S, Trippel T, Bach D, Bachran D, González A, López B, Wachter R, Hasenfuss G, Delles C, Dominiczak AF, Pieske B, Díez J, Edelmann F.

Eur J Heart Fail. 2018 Apr 30. doi: 10.1002/ejhf.1194. [Epub ahead of print]

PMID:
29709099
21.

[Comorbidities in heart failure : An interdisciplinary challenge].

von Haehling S, Hasenfuß G.

Internist (Berl). 2018 May;59(5):413-414. doi: 10.1007/s00108-018-0420-7. German. No abstract available.

PMID:
29654519
22.

Relationship between exercise intervention and NO pathway in patients with heart failure with preserved ejection fraction.

Baldassarri F, Schwedhelm E, Atzler D, Böger RH, Cordts K, Haller B, Pressler A, Müller S, Suchy C, Wachter R, Düngen HD, Hasenfuss G, Pieske B, Halle M, Edelmann F, Duvinage A.

Biomarkers. 2018 Sep;23(6):540-550. doi: 10.1080/1354750X.2018.1460762. Epub 2018 Apr 12.

PMID:
29619838
23.

Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study.

Hellenkamp K, Pruszczyk P, Jiménez D, Wyzgał A, Barrios D, Ciurzyński M, Morillo R, Hobohm L, Keller K, Kurnicka K, Kostrubiec M, Wachter R, Hasenfuß G, Konstantinides S, Lankeit M.

Eur Respir J. 2018 Apr 19;51(4). pii: 1702037. doi: 10.1183/13993003.02037-2017. Print 2018 Apr.

PMID:
29599188
24.

Inter-vendor reproducibility of left and right ventricular cardiovascular magnetic resonance myocardial feature-tracking.

Gertz RJ, Lange T, Kowallick JT, Backhaus SJ, Steinmetz M, Staab W, Kutty S, Hasenfuß G, Lotz J, Schuster A.

PLoS One. 2018 Mar 14;13(3):e0193746. doi: 10.1371/journal.pone.0193746. eCollection 2018. Erratum in: PLoS One. 2018 Jun 18;13(6):e0199489.

25.

Electromechanical vortex filaments during cardiac fibrillation.

Christoph J, Chebbok M, Richter C, Schröder-Schetelig J, Bittihn P, Stein S, Uzelac I, Fenton FH, Hasenfuß G, Gilmour RF Jr, Luther S.

Nature. 2018 Mar 29;555(7698):667-672. doi: 10.1038/nature26001. Epub 2018 Feb 21.

PMID:
29466325
26.

Genetic determinants of heart failure: facts and numbers.

Czepluch FS, Wollnik B, Hasenfuß G.

ESC Heart Fail. 2018 Jun;5(3):211-217. doi: 10.1002/ehf2.12267. Epub 2018 Feb 19.

27.

Cardiac Magnetic Resonance Myocardial Feature Tracking for Optimized Prediction of Cardiovascular Events Following Myocardial Infarction.

Eitel I, Stiermaier T, Lange T, Rommel KP, Koschalka A, Kowallick JT, Lotz J, Kutty S, Gutberlet M, Hasenfuß G, Thiele H, Schuster A.

JACC Cardiovasc Imaging. 2018 Feb 9. pii: S1936-878X(17)31176-2. doi: 10.1016/j.jcmg.2017.11.034. [Epub ahead of print]

PMID:
29454776
28.

Atrio-ventricular deformation and heart failure in Ebstein's Anomaly - A cardiovascular magnetic resonance study.

Steinmetz M, Broder M, Hösch O, Lamata P, Kutty S, Kowallick JT, Staab W, Ritter CO, Hasenfuß G, Paul T, Lotz J, Schuster A.

Int J Cardiol. 2018 Apr 15;257:54-61. doi: 10.1016/j.ijcard.2017.11.097. Epub 2018 Feb 3.

29.

A context-specific cardiac β-catenin and GATA4 interaction influences TCF7L2 occupancy and remodels chromatin driving disease progression in the adult heart.

Iyer LM, Nagarajan S, Woelfer M, Schoger E, Khadjeh S, Zafiriou MP, Kari V, Herting J, Pang ST, Weber T, Rathjens FS, Fischer TH, Toischer K, Hasenfuss G, Noack C, Johnsen SA, Zelarayán LC.

Nucleic Acids Res. 2018 Apr 6;46(6):2850-2867. doi: 10.1093/nar/gky049.

30.

Left ventricular synchrony, torsion, and recoil mechanics in Ebstein's anomaly: insights from cardiovascular magnetic resonance.

Steinmetz M, Usenbenz S, Kowallick JT, Hösch O, Staab W, Lange T, Kutty S, Lotz J, Hasenfuß G, Paul T, Schuster A.

J Cardiovasc Magn Reson. 2017 Dec 14;19(1):101. doi: 10.1186/s12968-017-0414-y.

31.

Transfemoral aortic valve implantation after cardiac transplantation.

Andrási TB, Danner BC, Grossmann M, Schöndube FA, HASENFUß G, Jacobshagen C.

J Cardiovasc Surg (Torino). 2018 Feb;59(1):143-145. doi: 10.23736/S0021-9509.17.09788-9. No abstract available.

PMID:
29231677
32.

Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction.

Bobenko A, Bartels I, Münch M, Trippel T, Lindhorst R, Nolte K, Herrmann-Lingen C, Halle M, Duvinage A, Düngen HD, Gelbrich G, Tschöpe C, Hasenfuss G, Wachter R, Pieske B, Edelmann F.

ESC Heart Fail. 2018 Feb;5(1):53-62. doi: 10.1002/ehf2.12227. Epub 2017 Dec 6.

33.

Echocardiographic Estimation of Mean Pulmonary Artery Pressure: A Comparison of Different Approaches to Assign the Likelihood of Pulmonary Hypertension.

Hellenkamp K, Unsöld B, Mushemi-Blake S, Shah AM, Friede T, Hasenfuß G, Seidler T.

J Am Soc Echocardiogr. 2018 Jan;31(1):89-98. doi: 10.1016/j.echo.2017.09.009. Epub 2017 Nov 23.

PMID:
29174340
34.

T helper cells with specificity for an antigen in cardiomyocytes promote pressure overload-induced progression from hypertrophy to heart failure.

Gröschel C, Sasse A, Röhrborn C, Monecke S, Didié M, Elsner L, Kruse V, Bunt G, Lichtman AH, Toischer K, Zimmermann WH, Hasenfuß G, Dressel R.

Sci Rep. 2017 Nov 22;7(1):15998. doi: 10.1038/s41598-017-16147-1.

35.

[Choosing Wisely: rationale, implementation, and evaluation].

Hasenfuß G, Fölsch UR.

Z Evid Fortbild Qual Gesundhwes. 2017 Dec;129:37-40. doi: 10.1016/j.zefq.2017.10.011. Epub 2017 Nov 20. German.

PMID:
29157561
36.

Klug Entscheiden-Initiative: Geschichte, Methodik, ethische Aspekte und internationale Verbreitung.

Hasenfuß G, Fölsch UR.

Z Evid Fortbild Qual Gesundhwes. 2017 Dec;129:1-2. doi: 10.1016/j.zefq.2017.11.001. Epub 2017 Nov 20. German. No abstract available.

PMID:
29157560
37.

Atropine augments cardiac contractility by inhibiting cAMP-specific phosphodiesterase type 4.

Perera RK, Fischer TH, Wagner M, Dewenter M, Vettel C, Bork NI, Maier LS, Conti M, Wess J, El-Armouche A, Hasenfuß G, Nikolaev VO.

Sci Rep. 2017 Nov 9;7(1):15222. doi: 10.1038/s41598-017-15632-x.

38.

Cardiomyocyte proliferation prevents failure in pressure overload but not volume overload.

Toischer K, Zhu W, Hünlich M, Mohamed BA, Khadjeh S, Reuter SP, Schäfer K, Ramanujam D, Engelhardt S, Field LJ, Hasenfuss G.

J Clin Invest. 2017 Dec 1;127(12):4285-4296. doi: 10.1172/JCI81870. Epub 2017 Oct 30.

39.

Echocardiographic evaluation of diastolic function in mouse models of heart disease.

Schnelle M, Catibog N, Zhang M, Nabeebaccus AA, Anderson G, Richards DA, Sawyer G, Zhang X, Toischer K, Hasenfuss G, Monaghan MJ, Shah AM.

J Mol Cell Cardiol. 2018 Jan;114:20-28. doi: 10.1016/j.yjmcc.2017.10.006. Epub 2017 Oct 19.

40.

Clinical Relevance of Patent Foramen Ovale and Atrial Septum Aneurysm in Stroke: Findings of a Single-Center Cross-Sectional Study.

Schnieder M, Siddiqui T, Karch A, Bähr M, Hasenfuss G, Liman J, Schroeter MR.

Eur Neurol. 2017;78(5-6):264-269. doi: 10.1159/000479962. Epub 2017 Sep 28.

PMID:
28957815
41.

Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.

Streckfuss-Bömeke K, Tiburcy M, Fomin A, Luo X, Li W, Fischer C, Özcelik C, Perrot A, Sossalla S, Haas J, Vidal RO, Rebs S, Khadjeh S, Meder B, Bonn S, Linke WA, Zimmermann WH, Hasenfuss G, Guan K.

J Mol Cell Cardiol. 2017 Dec;113:9-21. doi: 10.1016/j.yjmcc.2017.09.008. Epub 2017 Sep 21.

42.

Relevance of supraventricular runs detected after cerebral ischemia.

Weber-Krüger M, Lutz C, Zapf A, Stahrenberg R, Seegers J, Witzenhausen J, Wasser K, Hasenfuß G, Gröschel K, Wachter R.

Neurology. 2017 Oct 10;89(15):1545-1552. doi: 10.1212/WNL.0000000000004487. Epub 2017 Sep 13.

PMID:
28904084
43.

[Internal emergency cases at the interface of outpatient and inpatient].

Buerke M, Hasenfuß G, Hiddemann W, Sieber CC.

Internist (Berl). 2017 Sep;58(9):881-882. doi: 10.1007/s00108-017-0304-2. German. No abstract available.

PMID:
28828494
44.

Catecholamine-Dependent β-Adrenergic Signaling in a Pluripotent Stem Cell Model of Takotsubo Cardiomyopathy.

Borchert T, Hübscher D, Guessoum CI, Lam TD, Ghadri JR, Schellinger IN, Tiburcy M, Liaw NY, Li Y, Haas J, Sossalla S, Huber MA, Cyganek L, Jacobshagen C, Dressel R, Raaz U, Nikolaev VO, Guan K, Thiele H, Meder B, Wollnik B, Zimmermann WH, Lüscher TF, Hasenfuss G, Templin C, Streckfuss-Bömeke K.

J Am Coll Cardiol. 2017 Aug 22;70(8):975-991. doi: 10.1016/j.jacc.2017.06.061.

45.

Response by von Roeder et al to Letter Regarding Article, "Influence of Left Atrial Function on Exercise Capacity and Left Ventricular Function in Patients With Heart Failure and Preserved Ejection Fraction".

von Roeder M, Rommel KP, Kowallick JT, Blazek S, Besler C, Fengler K, Lotz J, Hasenfuß G, Lücke C, Gutberlet M, Schuler G, Schuster A, Lurz P.

Circ Cardiovasc Imaging. 2017 Aug;10(8). pii: e006785. doi: 10.1161/CIRCIMAGING.117.006785. No abstract available.

PMID:
28790126
46.

Quantitative assessment of left ventricular mechanical dyssynchrony using cine cardiovascular magnetic resonance imaging: Inter-study reproducibility.

Kowallick JT, Morton G, Lamata P, Jogiya R, Kutty S, Hasenfuß G, Lotz J, Chiribiri A, Nagel E, Schuster A.

JRSM Cardiovasc Dis. 2017 May 15;6:2048004017710142. doi: 10.1177/2048004017710142. eCollection 2017 Jan-Dec.

47.

Low-flow/low-gradient aortic stenosis-Still a diagnostic and therapeutic challenge.

Vogelgesang A, Hasenfuss G, Jacobshagen C.

Clin Cardiol. 2017 Sep;40(9):654-659. doi: 10.1002/clc.22728. Epub 2017 May 23. Review.

48.

[Choosing Wisely-evidence-based].

Hasenfuß G, Märker-Hermann E, Hallek M, Sieber CC, Fölsch UR.

Internist (Berl). 2017 Jun;58(6):525-526. doi: 10.1007/s00108-017-0253-9. German. No abstract available.

PMID:
28536760
49.

Exercise training in Diastolic Heart Failure (Ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial.

Edelmann F, Bobenko A, Gelbrich G, Hasenfuss G, Herrmann-Lingen C, Duvinage A, Schwarz S, Mende M, Prettin C, Trippel T, Lindhorst R, Morris D, Pieske-Kraigher E, Nolte K, Düngen HD, Wachter R, Halle M, Pieske B.

Eur J Heart Fail. 2017 Aug;19(8):1067-1074. doi: 10.1002/ejhf.862. Epub 2017 May 17. Review.

50.

[Response to and further development of the Choosing wisely initiative].

Fölsch UR, Hallek M, Raupach T, Hasenfuß G.

Internist (Berl). 2017 Jun;58(6):527-531. doi: 10.1007/s00108-017-0246-8. Review. German.

PMID:
28477038

Supplemental Content

Loading ...
Support Center